USE OF PEGYLATED INTERFERON ALFA-2A (PEG-IFN) IN THE SECOND LINE TREATMENT OF CHRONIC MYELOPROLIFERATIVE NEOPLASMS (NMP): EXPERIENCE OF THE CATALAN INSTITUTE OF ONCOLOGY (ICO)
HAEMATOLOGICA（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined